Professor Anna Nowak is the director of Perth-based National Centre for Asbestos Related Disease. Here she talks about the centre’s international research on combining immunotherapy with more traditional cancer therapies, including the DREAM3R clinical trial in Australia and the US.
Interview with Professor Anna Nowak from the National Centre for Asbestos Related Diseases.
Music: https://www.bensound.com National Centre for Asbestos Related Diseases: https://ncard.org.au/